GLENMARK.BO

Glenmark Pharmaceuticals Limited
BSEINREQUITY DELAYED
Last price
2,306.00
▼ 19.00 (0.82%)
MARKET ·

Price

Open
2,333.00
Prev close
2,325.00
Day high
2,346.60
Day low
2,304.85
Volume
6.29K
Market cap
P/E (TTM)
52W range
1,794.00 – 2,471.05

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+1.34% +2.7%
1M
+5.77% +2.0%
3M
-0.45% -3.6%
6M
+14.07% +3.0%
YTD
+14.20% +1.9%
1Y
+14.43% -5.6%
3Y
+188.25% +114.1%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
2,299.36
+0.29% from price
SMA 20
2,260.11
+2.87% from price
SMA 50
2,232.34
+4.15% from price
SMA 100
2,250.50
+2.47% from price
SMA 200
2,126.71
+9.32% from price
EMA 12
2,288.93
+0.75% from price
EMA 26
2,267.81
+1.68% from price
EMA 50
2,251.77
+2.41% from price
RSI (14)
57.1
Neutral
MACD (12,26,9)
21.12
Hist 3.90
ATR (14)
56.90
2.45% of price
Realised vol 30D
25.4%
Annualised
Bollinger upper
2,361.27
20, 2σ
Bollinger lower
2,158.96
20, 2σ
50 / 200 cross
Golden
2,232.34 vs 2,126.71
Trend bias
Above 200
+9.32%

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.08
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
25.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-15.0%
Peak to trough
Max drawdown 5Y
-34.6%
Peak to trough
ATR 14
56.90
2.45% of price
Beta (reported)
5Y monthly, from filing

Options chain

Account required
ExpirySpot 2,306.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.